Page last updated: 2024-11-05

theobromine and Liver Cirrhosis

theobromine has been researched along with Liver Cirrhosis in 6 studies

Theobromine: 3,7-Dimethylxanthine. The principle alkaloid in Theobroma cacao (the cacao bean) and other plants. A xanthine alkaloid that is used as a bronchodilator and as a vasodilator. It has a weaker diuretic activity than THEOPHYLLINE and is also a less powerful stimulant of smooth muscle. It has practically no stimulant effect on the central nervous system. It was formerly used as a diuretic and in the treatment of angina pectoris and hypertension. (From Martindale, The Extra Pharmacopoeia, 30th ed, pp1318-9)
theobromine : A dimethylxanthine having the two methyl groups located at positions 3 and 7. A purine alkaloid derived from the cacao plant, it is found in chocolate, as well as in a number of other foods, and is a vasodilator, diuretic and heart stimulator.

Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.

Research Excerpts

ExcerptRelevanceReference
"Apparent pharmacokinetic parameters of caffeine elimination from the circulation were determined in 27 patients with histologically confirmed liver cirrhosis, 8 patients with miscellaneous liver disease, and 8 patients with other than liver disease."7.67Correlation of caffeine elimination and Child's classification in liver cirrhosis. ( Gerok, W; Haag, K; Holstege, A; Staiger, M, 1989)
" These findings suggest that CA pharmacokinetic parameters can be estimated using a simplified three-point blood sampling procedure following a single oral load and that the serum PX/CA or (PX + TB + TP)/CA ratio in a single blood sample taken 2 or 4 h after dosing provides a useful indicator for the assessment of hepatic drug-oxidizing capacity, N-demethylation, in decompensated liver cirrhosis."5.28A simple useful method for the determination of hepatic function in patients with liver cirrhosis using caffeine and its three major dimethylmetabolites. ( Fukao, K; Ishikawa, A; Iwasaki, Y; Misawa, S; Osada, A; Tanaka, E; Tsuji, K; Yamamoto, Y, 1992)
"Apparent pharmacokinetic parameters of caffeine elimination from the circulation were determined in 27 patients with histologically confirmed liver cirrhosis, 8 patients with miscellaneous liver disease, and 8 patients with other than liver disease."3.67Correlation of caffeine elimination and Child's classification in liver cirrhosis. ( Gerok, W; Haag, K; Holstege, A; Staiger, M, 1989)
"Subjects with liver cirrhosis and chronic hepatitis, as well as healthy volunteers, were given the oral dose of 300 mg caffeine."2.71Serum metabolite/caffeine ratios as a test for liver function. ( Flieger, J; Jodynis-Liebert, J; Juszczyk, J; Matuszewska, A, 2004)
" These findings suggest that CA pharmacokinetic parameters can be estimated using a simplified three-point blood sampling procedure following a single oral load and that the serum PX/CA or (PX + TB + TP)/CA ratio in a single blood sample taken 2 or 4 h after dosing provides a useful indicator for the assessment of hepatic drug-oxidizing capacity, N-demethylation, in decompensated liver cirrhosis."1.28A simple useful method for the determination of hepatic function in patients with liver cirrhosis using caffeine and its three major dimethylmetabolites. ( Fukao, K; Ishikawa, A; Iwasaki, Y; Misawa, S; Osada, A; Tanaka, E; Tsuji, K; Yamamoto, Y, 1992)
"001) and no significant differences were observed in the pharmacokinetic data derived from the respective concentration-time curves."1.28The pharmacokinetics of caffeine and its dimethylxanthine metabolites in patients with chronic liver disease. ( Chakraborty, J; Marks, V; Morgan, MY; Scott, NR; Stambuk, D, 1989)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jodynis-Liebert, J1
Flieger, J1
Matuszewska, A1
Juszczyk, J1
Holstege, A2
Kurz, M1
Weinbeck, M1
Gerok, W2
Koppenhagen, K1
Wenig, HG1
Tanaka, E1
Ishikawa, A1
Yamamoto, Y1
Osada, A1
Tsuji, K1
Fukao, K1
Misawa, S1
Iwasaki, Y1
Scott, NR1
Stambuk, D1
Chakraborty, J1
Marks, V1
Morgan, MY1
Staiger, M1
Haag, K1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Development of a Breath Test for Monitoring Liver Metabolic Function in Patients With Chronic Liver Disease and Cirrhosis[NCT00244569]Phase 3120 participants (Anticipated)Interventional2005-09-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

2 trials available for theobromine and Liver Cirrhosis

ArticleYear
Serum metabolite/caffeine ratios as a test for liver function.
    Journal of clinical pharmacology, 2004, Volume: 44, Issue:4

    Topics: Adult; Caffeine; Female; Hepatitis, Chronic; Humans; Liver; Liver Cirrhosis; Liver Function Tests; M

2004
[The effect of pentoxifylline on liver perfusion: a comparative study in patients with liver diseases and in normal subjects, using 198Au-colloid-scintigraphy (author's transl)].
    Medizinische Klinik, 1979, Aug-31, Volume: 74, Issue:35

    Topics: Adult; Aged; Chronic Disease; Female; Hepatitis; Humans; Liver; Liver Circulation; Liver Cirrhosis;

1979

Other Studies

4 other studies available for theobromine and Liver Cirrhosis

ArticleYear
Excretion of caffeine and its primary degradation products into bile.
    Journal of hepatology, 1993, Volume: 17, Issue:1

    Topics: Adult; Aged; Bile; Bilirubin; Caffeine; Chromatography, High Pressure Liquid; Female; Humans; Liver

1993
A simple useful method for the determination of hepatic function in patients with liver cirrhosis using caffeine and its three major dimethylmetabolites.
    International journal of clinical pharmacology, therapy, and toxicology, 1992, Volume: 30, Issue:9

    Topics: Adult; Caffeine; Evaluation Studies as Topic; Female; Humans; Liver; Liver Cirrhosis; Male; Methods;

1992
The pharmacokinetics of caffeine and its dimethylxanthine metabolites in patients with chronic liver disease.
    British journal of clinical pharmacology, 1989, Volume: 27, Issue:2

    Topics: Adult; Aged; Caffeine; Female; Half-Life; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middl

1989
Correlation of caffeine elimination and Child's classification in liver cirrhosis.
    Klinische Wochenschrift, 1989, Jan-04, Volume: 67, Issue:1

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Caffeine; Chromatography, High Pressure Liquid

1989